A paper doesn't "prove" anything, but it does utilize and cite upon real world mobility data and real world susceptibility and transmissibility data for many diseases, including early estimates of these for SARS-CoV-2, e.g. https://wellcomeopenresearch.org/articles/5-67 is cited and used in the estimate of the coefficient of variation.

There was very little data on overdispersion and differential susceptibility for SARS-CoV-2 at the time that paper was written, but there was some. What existed at the time was in line with the better estimates from SARS-CoV-1, etc, that the paper also used. Further evidence has emerged since, both of variable susceptibility and exposure and of actual mechanisms of variable susceptibility-- some surprising like https://www.medrxiv.org/content/10.1101/2020.04.08.20058073v...